1. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
    Wen Fong Ooi et al, 2016, Nature Communications CrossRef
  2. Reduction of miR-132-3p contributes to gastric cancer proliferation by targeting MUC13
    Liang He et al, 2017, Molecular Medicine Reports CrossRef
  3. AKT drives sustained motility following MEK inhibition via promoting SNAIL and AXL in MDA-MB-231 LM2
    Junyeob Kwon et al, 2020, Biochemical and Biophysical Research Communications CrossRef
  4. Expression of HER2/c-erbB-2, EGFR protein in gastric carcinoma and its clinical significance
    Guoxiong Cheng et al, 2019, Open Life Sciences CrossRef
  5. Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
    Ofra Novoplansky et al, 2023, Molecular Oncology CrossRef
  6. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer
    Wengui Shi et al, 2021, Nature Communications CrossRef
  7. The association between EGFR expression and clinical pathology characteristics in gastric cancer
    Yong Chen et al, 2016, Open Life Sciences CrossRef
  8. Cetuximab improves AZD6244 antitumor activity in colorectal cancer HT29 cells in vitro and in nude mice by attenuating HER3/Akt pathway activation
    Qin Zhang et al, 2018, Oncology Letters CrossRef
  9. MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701
    Chia‐Hung Chen et al, 2017, Molecular Oncology CrossRef
  10. Natural products targeting the MAPK-signaling pathway in cancer: overview
    Aiwen Shi et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
  11. Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma
    Yufei Liang et al, 2019, Gastroenterology Research and Practice CrossRef
  12. Potential drug–drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma
    A. Marani et al, 2023, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  13. Blocking the JAK2/STAT3 and ERK pathways suppresses the proliferation of gastrointestinal cancers by inducing apoptosis
    Xi Wang et al, 2021, Journal of Zhejiang University-SCIENCE B CrossRef